Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 274, pseudogene (RN7SL274P) is a human pseudogene annotated as a non-coding RNA derived from the 7SL RNA gene, which encodes the RNA component of the signal recognition particle (SRP)[1][6]. While the canonical 7SL RNA is an essential element of the SRP complex involved in directing newly synthesized secretory proteins to the endoplasmic reticulum membrane[3][7], RN7SL274P itself is classified as a **pseudogene**, meaning it is a genomic sequence similar to the 7SL RNA gene but generally non-functional: it no longer produces a functional product due to accumulated mutations or truncations[9][5][1]. There are hundreds of similar 7SL pseudogenes in the human genome, most of which are truncated and not expressed[5][9]. Pseudogenes like RN7SL274P are generally not considered therapeutic targets, receptors, enzymes, or molecular entities of pharmacological interest. However, recent literature suggests some pseudogenes may have *regulatory roles* by acting as decoys for microRNAs, influencing gene expression of their parent genes, especially in cancer biology[2]. There is **no evidence** that RN7SL274P has an established or characterized biological or pathological function, nor is it known to interact with any drugs, serve as a biomarker, or pose direct safety concerns. Thus, it primarily serves as an annotated genomic feature with potential (but unproven) non-coding regulatory capacity, as is being increasingly explored for pseudogenes generally[2][5][9]. If you require data on the functional 7SL RNA gene or the signal recognition particle itself, those would need to be specifically requested, as this entry refers solely to a non-functional, noncoding pseudogene[1][5][6][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 274, pseudogene (RN7SL274P).